【24h】

Endoscopic reconstruction of anterior and middle cranial fossa defects using acellular dermal allograft.

机译:内镜下使用脱细胞异体真皮移植重建颅前窝和中颅窝缺损。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To report our experience in reconstructing defects of the anterior and middle cranial fossa skull base using endoscopic placement of acellular dermal allograft (AlloDerm, LifeCell Corp., The Woodlands, TX). STUDY DESIGN: Retrospective chart review. METHODS: In all cases, the skull base repair was completed with a similar technique. After identification of the defect boundaries, endoscopic transnasal repair was performed through placement of a layered reconstruction of acellular dermal allograft, septal bone/cartilage, and acellular dermal allograft, which were all placed on the intracranial side of the defect. A mucosal free graft was draped over the reconstruction. Fibrin glue was used to hold the mucosal graft in place, and the reconstruction was supported by both absorbable and nonabsorbable nasal packing. RESULTS: Eight patients with nine skull base defects underwent the procedure for repair of cerebrospinal fluid rhinorrhea. All defects were successfully repaired. One patient underwent successful reconstruction of bilateral ethmoid roof defects that resulted from endoscopic resection of ethmoid adenocarcinoma. Twenty-four patients underwent primary resection of hypophyseal adenomas. Twenty-three patients had macroadenomas, and intraoperative cerebrospinal fluid leaks were noted in 11 patients. Sellar repairs after trans-sphenoidal hypophysectomy were successful in 22 of 24 patients. One patient with hypophysectomy required reoperation (1 of 24 [4%]) for secondary closure of a cerebrospinal fluid leak. Serious complications were avoided in all patients. Patients were followed for a period ranging from 5 to 57 months (mean period, 34 mo). CONCLUSIONS: Acellular dermal allograft can be successfully used for the reconstruction of anterior and middle cranial fossa skull base defects. This allograft, which is easy to manipulate endoscopically, provides an effective seal and barrier in skull base reconstruction and avoids the need for a donor site.
机译:目的:报告我们通过内镜放置脱细胞真皮同种异体移植物(AlloDerm,LifeCell Corp.,Woodlands,TX)重建前颅中窝颅骨颅骨缺损的经验。研究设计:回顾性图表审查。方法:在所有情况下,颅骨基部修复均采用类似技术完成。在确定缺损边界后,通过放置无细胞真皮异体移植物,隔骨/软骨和无细胞真皮异体移植物的分层重建物进行内窥镜经鼻修复,所有这些都放置在缺损的颅内侧。粘膜游离移植物覆盖重建。使用纤维蛋白胶将粘膜移植物固定在适当的位置,并通过可吸收和不可吸收的鼻腔填充物支持重建。结果:8例颅底有9处缺损的患者接受了脑脊液鼻漏的修复。所有缺陷均已成功修复。一名患者成功进行了内镜切除筛窦腺癌导致的双侧筛窦屋顶缺损的成功重建。初次切除垂体腺瘤的患者为24例。 23例患有大腺瘤,11例出现术中脑脊液漏。经蝶骨垂体后叶切除术后鞍膜修复成功的24例中的22例。一名进行垂体切除术的患者需要再次手术(24例中的1例[4%]),以继发性关闭脑脊液漏。所有患者均避免了严重的并发症。随访患者5到57个月(平均34个月)。结论:脱细胞异体真皮移植可成功用于颅前窝和颅中颅骨颅底缺损的修复。这种同种异体移植易于内窥镜操作,可在颅底重建中提供有效的密封和屏障,并且无需供体部位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号